Atlas FDA

OOU

5 FDA 510(k) clearances · Product code

85 daysmedian time to decision
221 days90th percentile
5clearances measured

FDA profile

Official device name
Parainfluenza Multiplex Nucleic Acid Assay
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3980
Medical specialty
Microbiology
FDA definition
A parainfluenza multiplex nucleic acid assay is a multiplex in vitro diagnostic test for the simultaneous qualitative detection and discrimination of parainfluenza 1 virus, parainfluenza 2 virus, parainfluenza 3 virus and parainfluenza 4 virus nucleic acids isolated and purified from human respiratory specimens obtained from individuals exhibiting signs and symptoms of respiratory tract infections or viral culture. The detection and discrimination of human parainfluenza nucleic acids from symptomatic patients aid in the diagnosis of human respiratory tract parainfluenza infections if used in conjunction with other clinical and laboratory findings.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
Panther Fusion Paraflu Assay (K172282)Hologic, Inc.2017-10-23
ProParaFlu+ Assay (K153223)Hologic, Inc.2015-12-09
LYRA PARAINFLUENZA VIRUS ASSAY (K141927)Quidel Corporation2014-10-09
PROPARAFLU+ ASSAY (K132238)Gen-Probe Prodesse, Inc.2013-08-26
PROPARAFLU+ASSAY (K091053)Prodesse, Inc.2009-11-20

Track OOU automatically

Every clearance here is in the API, with alerts when new ones post.